Enzyme Fragment Complementation Platform
- Version:
- 20832
- File Name/Number:
- 20832
- Year:
- 2018
Advance your therapeutic drug screening and development programs with Enzyme Fragment Complementation (EFC) assay platform technology to get functionally relevant data. The patented EFC platform is a homogeneous detection technology that enables drug discovery researchers to measure and rank ligand potencies, perform functional screens, quantify ligand levels, identify novel compounds, and much more. Discover how EFC technology can progress your programs.